These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36943183)

  • 1. Advances in determining new treatments for hepatitis B infection by utilizing existing and novel biomarkers.
    Mak LY; Hui RW; Cheung KS; Fung J; Seto WK; Yuen MF
    Expert Opin Drug Discov; 2023 Apr; 18(4):401-416. PubMed ID: 36943183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatments.
    Laupèze B; Vassilev V; Badur S
    Expert Rev Gastroenterol Hepatol; 2023; 17(11):1135-1147. PubMed ID: 37847193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research progress of biomarkers of hepatitis B virus and clinical significance].
    Wang X; Tang X; Han N; Tang H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2023 Dec; 40(6):1242-1248. PubMed ID: 38151949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of different viral biomarkers on the management of chronic hepatitis B.
    Mak LY; Hui RW; Fung J; Seto WK; Yuen MF
    Clin Mol Hepatol; 2023 Apr; 29(2):263-276. PubMed ID: 36655304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Biomarkers in Guiding Cure of Viral Hepatitis B.
    Buti M; Riveiro-Barciela M; Rodríguez-Frías F; Tabernero D; Esteban R
    Semin Liver Dis; 2020 Feb; 40(1):49-60. PubMed ID: 31805583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the developing pharmacotherapeutic landscape in hepatitis B treatment: a spotlight on drugs in phase II clinical trials.
    Hui RW; Mak LY; Seto WK; Yuen MF
    Expert Opin Emerg Drugs; 2022 Jun; 27(2):127-140. PubMed ID: 35511483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients.
    García-López M; Lens S; Pallett LJ; Testoni B; Rodríguez-Tajes S; Mariño Z; Bartres C; García-Pras E; Leonel T; Perpiñán E; Lozano JJ; Rodríguez-Frías F; Koutsoudakis G; Zoulim F; Maini MK; Forns X; Pérez-Del-Pulgar S
    J Hepatol; 2021 May; 74(5):1064-1074. PubMed ID: 33278456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure.
    Moini M; Fung S
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B core-related antigen: Are we near a treatment endpoint?
    Gupta T
    World J Gastroenterol; 2022 Jul; 28(27):3532-3534. PubMed ID: 36158266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developments in pharmacotherapeutic agents for hepatitis B - how close are we to a functional cure?
    Khan N; Almajed MR; Fitzmaurice MG; Jafri SM
    Expert Opin Pharmacother; 2023 Jun; 24(9):1001-1011. PubMed ID: 37163255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New viral biomarkers for Hepatitis B: Are we able to change practice?
    Höner Zu Siederdissen C; Maasoumy B; Cornberg M
    J Viral Hepat; 2018 Nov; 25(11):1226-1235. PubMed ID: 30187603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference as a novel treatment strategy for chronic hepatitis B infection.
    Hui RW; Mak LY; Seto WK; Yuen MF
    Clin Mol Hepatol; 2022 Jul; 28(3):408-424. PubMed ID: 35172540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on hepatitis B virus infection.
    You CR; Lee SW; Jang JW; Yoon SK
    World J Gastroenterol; 2014 Oct; 20(37):13293-305. PubMed ID: 25309066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of intrahepatic hepatitis B virus covalently closed circular DNA and total DNA in patients with acute hepatitis B and patients with chronic hepatitis B receiving anti‑viral treatment.
    Ruan P; Zhou B; Dai X; Sun Z; Guo X; Huang J; Gong Z
    Mol Med Rep; 2014 Apr; 9(4):1135-41. PubMed ID: 24566465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel developments of hepatitis B: treatment goals, agents and monitoring tools.
    Mak LY; Seto WK; Fung J; Yuen MF
    Expert Rev Clin Pharmacol; 2019 Feb; 12(2):109-120. PubMed ID: 30621472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B.
    Mak LY; Wong D; Kuchta A; Hilfiker M; Hamilton A; Chow N; Mao X; Seto WK; Yuen MF
    Clin Mol Hepatol; 2023 Jan; 29(1):146-162. PubMed ID: 35989092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of the new serum markers in the research and development of innovative hepatitis B drugs].
    Lu FM; Wang J; Chen XM; Zhang XX; Zhang WH; Xu XY; Jia JD; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):649-653. PubMed ID: 32911901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.
    Bayliss J; Yuen L; Rosenberg G; Wong D; Littlejohn M; Jackson K; Gaggar A; Kitrinos KM; Subramanian GM; Marcellin P; Buti M; Janssen HLA; Gane E; Sozzi V; Colledge D; Hammond R; Edwards R; Locarnini S; Thompson A; Revill PA
    Gut; 2017 Nov; 66(11):2013-2023. PubMed ID: 27534671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The scientific basis of combination therapy for chronic hepatitis B functional cure.
    Lim SG; Baumert TF; Boni C; Gane E; Levrero M; Lok AS; Maini MK; Terrault NA; Zoulim F
    Nat Rev Gastroenterol Hepatol; 2023 Apr; 20(4):238-253. PubMed ID: 36631717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of sustained functional cure in hepatitis B envelope antigen-negative patients achieving hepatitis B surface antigen seroclearance with interferon-alpha-based therapy.
    Li MH; Yi W; Zhang L; Lu Y; Lu HH; Shen G; Wu SL; Hao HX; Gao YJ; Chang M; Liu RY; Hu LP; Cao WH; Chen QQ; Li JN; Wan G; Xie Y
    J Viral Hepat; 2019 Jul; 26 Suppl 1():32-41. PubMed ID: 31380582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.